MVM Life Science Partners: Partners and Investors

8 investors · 4 with verified email

MVM Life Science Partners has 8 investors on VCSift, 4 with a verified email address. Roles include Partner, Founder & Managing Partner and Finance Partner. The team invests at Early Stage stage. Sector focus: Marketing, Investment Management and Advertising. Based in United States and United Kingdom (London, Boston).

8 investors

Investors and partners at MVM Life Science Partners

KD

Kyle Dempsey

MVM Life Science Partners

Angel Investor
Early Stage Marketing Investment Management Advertising
NA

Neil Akhurst

MVM Life Science Partners

Angel Investor
Early Stage Marketing Investment Management Advertising
HH

Hugo Harrod

MVM Life Science Partners

Angel Investor
Early Stage Marketing Investment Management Advertising
EB

Eric Bednarski

MVM Life Science Partners

Angel Investor
Early Stage Marketing Investment Management Advertising
NA

Neil Akhurst

Finance Partner · MVM Life Science Partners

London, UK VC Firm
TC

Thomas Casdagli

Partner · MVM Life Science Partners

London, UK Angel Investor
EB

Eric Bednarski

Partner · MVM Life Science Partners

Boston, US Angel Investor
SR

Stephen Reeders

Founder & Managing Partner · MVM Life Science Partners

US Angel Investor

How to pitch MVM Life Science Partners

  • Match the stage. Most MVM Life Science Partners investors on VCSift are tagged Early Stage. A round outside that range is usually a pass before the deck is opened.
  • Lead with the sector fit. The team's tagged focus is Marketing, Investment Management and Advertising. Name the thesis overlap in the first two lines of the email.
  • Pick the right person. Titles on the team include Partner, Founder & Managing Partner and Finance Partner. Partners and principals source deals; associates screen them. Write to the person whose portfolio is closest to yours.
  • Use a direct email. 4 of the 8 MVM Life Science Partners profiles include a verified address, which beats a website form or a cold LinkedIn message.

MVM Life Science Partners investors by country